Evidence map›Paper›PMID 41204776›Full record

ArticleHealth (London, England : 1997)2026

Making 'safer injecting' matter for people who inject image and performance enhancing drugs.

Timothy Piatkowski, Emma Kill, Sonya Weith, Steph Reeve, Luke Cox, Ross Coomber, Cheneal Puljevic, Thomas O'Connor, Jason Ferris

Abstract read
In one paragraph

Article in Health (London, England : 1997), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Timothy PiatkowskiGriffith University, Gold Coast, QLD, Australia.ORCID 0000-0002-6177-0266
Emma KillGriffith University, Gold Coast, QLD, Australia.
Sonya WeithQueensland Injectors Voice for Advocacy and Action, Sunshine Coast, Australia.
Steph ReeveGriffith University, Gold Coast, QLD, Australia.
Luke CoxSwansea University, Wales, UK.
Ross CoomberUniversity of Liverpool, UK.
Cheneal PuljevicThe University of Queensland, Brisbane, Australia.
Thomas O'ConnorUniversity of Connecticut School of Medicine, Farmington, USA.
Jason FerrisThe University of Queensland, Brisbane, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image and performance-enhancing drugs (IPEDs) are primarily injected intramuscularly or subcutaneously, yet traditional harm reduction strategies, focused on blood-borne virus prevention, often overlook the specific health enhancement goals of people who use IPEDs. This study advocates for a collaborative approach to safer injecting practices, informed by the lived-living experiences of people injecting IPEDs, to develop targeted messaging that aligns with their unique motivations. Thirty participants who inject IPEDs were recruited through community networks and partnerships. The study used qualitative focus groups and semi-structured interviews to explore injection practices and safety strategies. Data analysis followed an inductive, line-by-line approach, identifying themes related to injection methods and safer techniques, drawing on matters-of-concern. Stigma and misinformation about IPED injection practices were prevalent, contributing to a heightened risk of infection. Participants expressed anxiety about injection site reactions and reported limited knowledge of safe techniques, with poor injecting literacy leading to risky behaviours like needle reuse and inadequate hygiene. Importantly, participants highlighted that IPED injecting knowledge is often shared through peer support networks. This research calls for reframing harm reduction to focus on health enhancement, optimising injecting techniques, and integrating evidence-based resources, empowering peer-led harm reduction to better support the health aspirations of this population.

Indexed as

Harm ReductionHealth Knowledge, Attitudes, PracticePerformance-Enhancing SubstancesSubstance Abuse, IntravenousAdultFemaleFocus GroupsHumansInterviews as TopicMaleMiddle AgedQualitative ResearchRisk-TakingPerformance-Enhancing Substancesanabolic-androgenic steroidsblood-borne virusimage and performance enhancing drugsinfectioninjecting

Identifiers

PMID41204776
PMCPMC13272838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.